Presentation TCT 2012 <b>Pharmacodynamic Effect of Double-dose Clopidogrel versus Adding Dipyridamole In Patients With High On-treatment Platelet Reactivity (ACCEL-DIP) study</b> Presenter: Yongwhi Park, Young-Hoon Jeong, Jeong-Rang Park, Seok-Jae Hwang, Choong Hwan Kwak, Jin-Yong Hwang January 03, 2012
Presentation TCT 2012 Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel Presenter: Jean-Pierre P. Dery, Abdelouahed Khalil, Ugo D?ry, M?lanie Roy, Pierluigi Tricoci, Richard Becker, Stéphane Rinfret, Éric Larose, G?rald Barbeau, Robert DeLarochelli?re, Josep Rod?s-Cabau, Olivier F. Bertrand January 03, 2012
News Daily News Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response January 03, 2012
Presentation TCT 2012 Inhibition of Platelet Aggregation by Prostaglandin E1 (PGE1) May Be Attenuated in Diabetic Patients During Therapy with Clopidogrel Presenter: Rolf P. Kreutz, Perry Nystrom, Yvonne Kreutz, Jiao Miao, Richard Kovacs, David Flockhart, Zeruesenay Desta, Yan Jin January 03, 2012
Presentation TCT 2012 Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention Presenter: Andr?s Kom?csi, Orsolya Rideg, Gy?ngyv?r K?lt?, Andr?s Vorobcsuk, Daniel Aradi January 03, 2012
Presentation TCT 2012 Genetic Determinants of Clopidogrel Responsiveness in Koreans Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuk Kang, Hyo Suk Ahn, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim January 03, 2012
Presentation TCT 2012 CYP3A4 Genetic Status May Be Associated with Increased Vulnerability to the Adverse Effect of Calcium Channel Blockers on Clopidogrel Response Variability Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuk Kang, Hyo Suk Ahn, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim January 03, 2012
Presentation CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events Presenter: Michael V. Holmes January 03, 2012
Presentation TCT 2012 Clopidogrel Hyporesponsiveness, Interacting with Diabetes Mellitus, Predicts 2-Year Cardiovascular Outcome Among Taiwanese Population Underging Percutaneous Coronary Intervention Presenter: Ping-Yen Liu, Ling-Jay Hsu, Po-Tseng Lee, Cheng-Hann Lee, Ju-Yi Chen, Yi-Heng Li, Liang-Miin Tsai, Jyh-Hong Chen January 03, 2012
News Daily News Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All Yael L. Maxwell December 14, 2011
News Daily News New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought December 13, 2011
News Daily News FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI L.A. McKeown December 08, 2011
News Conference News SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel November 21, 2011
News Conference News Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity November 17, 2011
News Conference News Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes November 16, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011